TrialDiabetologia2019

Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes.

Myo Myo Aung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.